Safety and tolerability of pioglitazone, metformin, and gliclazide in the treatment of type 2 diabetes.
This analysis compares the safety and tolerability of pioglitazone (a thiazolidinedione), metformin (a biguanide), and gliclazide (a sulfonylurea). Data collected from four 1-year, double-blind studies comparing treatment of over 3700 patients with type 2 diabetes with pioglitazone, metformin, or gl...
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Conference item |
| Julkaistu: |
2005
|